Literature DB >> 1520286

Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.

M Mörike1, R E Brenner, G B Bushart, W M Teller, U Vetter.   

Abstract

Collagen produced in vitro by bone cells isolated from 19 patients with different forms of osteogenesis imperfecta (OI) was analysed. Clinically, four patients were classified as OI type I, 10 patients as OI type III and five patients as OI type IV. Bone cells of 12 of the 19 OI patients produced structurally abnormal type I collagen. Electrophoretically uniformly slower migrating collagen type I alpha-chains were found in one case of OI type I, in seven cases of OI type III and in one case of OI type IV; two cultures of OI type III produced two different populations of collagen type I alpha-chains, and one culture of OI type IV showed reduction-sensitive dimer formation of alpha 1(I) chains, resulting from the inadequate incorporation of a cysteine residue into the triple helical domain of alpha 1(I). Quantitative analysis of collagen metabolism led to the distinction of two groups of cultured OI osteoblasts. In osteoblasts of OI type I, mainly production of collagen was decreased, whereas secretion, processing and pericellular accumulation of (pro)collagen type I was similar to that in control osteoblasts. In contrast, in osteoblasts of OI types III and IV, production as well as secretion, processing and pericellular accumulation of (pro)collagen type I were significantly decreased. Low levels of type I collagen were found irrespective of the presence or absence of structural abnormalities of collagen type I in all OI types.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520286      PMCID: PMC1133019          DOI: 10.1042/bj2860073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Altered collagen metabolism in osteogenesis imperfecta fibroblasts: a study on 33 patients with diverse forms.

Authors:  R E Brenner; U Vetter; A Nerlich; O Wörsdorfer; W M Teller; P K Müller
Journal:  Eur J Clin Invest       Date:  1990-02       Impact factor: 4.686

2.  Kinetics of processing of type I and type III procollagens in fibroblast cultures.

Authors:  B Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

3.  Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures.

Authors:  M Wiestner; T Krieg; D Hörlein; R W Glanville; P Fietzek; P K Müller
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Molecular basis of osteogenesis imperfecta.

Authors:  D W Hollister
Journal:  Curr Probl Dermatol       Date:  1987

6.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

7.  A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.

Authors:  C D Constantinou; K B Nielsen; D J Prockop
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  Detection of cell-associated aminoterminal procollagen peptidase activity in cultured fibroblasts.

Authors:  D L Layman
Journal:  Proc Soc Exp Biol Med       Date:  1981-03

9.  Collagen: an overview.

Authors:  E J Miller; S Gay
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

10.  Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b.

Authors:  J E Puzas; J S Brand; K V Jackman
Journal:  Bone Miner       Date:  1986-10
View more
  2 in total

Review 1.  Osteogenesis imperfecta: from phenotype to genotype and back again.

Authors:  R Smith
Journal:  Int J Exp Pathol       Date:  1994-08       Impact factor: 1.925

2.  Expression of osteoblastic markers in cultured human bone and fracture callus cells.

Authors:  M Mörike; M Schulz; A Nerlich; M Koschnik; W M Teller; U Vetter; R E Brenner
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.